FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 5.343
AS - Asia 2.917
EU - Europa 1.520
SA - Sud America 508
AF - Africa 54
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.352
Nazione #
US - Stati Uniti d'America 5.223
SG - Singapore 1.149
CN - Cina 867
BR - Brasile 431
UA - Ucraina 311
DE - Germania 306
HK - Hong Kong 277
VN - Vietnam 202
TR - Turchia 196
GB - Regno Unito 173
IT - Italia 167
FI - Finlandia 148
SE - Svezia 109
RU - Federazione Russa 89
MX - Messico 61
ID - Indonesia 58
CA - Canada 48
PL - Polonia 47
IN - India 41
FR - Francia 38
AT - Austria 28
BD - Bangladesh 28
AR - Argentina 26
ZA - Sudafrica 26
ES - Italia 22
NL - Olanda 17
JP - Giappone 16
CZ - Repubblica Ceca 14
EC - Ecuador 14
LT - Lituania 14
IQ - Iraq 12
VE - Venezuela 11
CL - Cile 8
KE - Kenya 8
PK - Pakistan 8
PY - Paraguay 8
AU - Australia 7
BE - Belgio 7
KR - Corea 7
MA - Marocco 7
TW - Taiwan 6
CH - Svizzera 5
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
RO - Romania 5
UZ - Uzbekistan 5
IE - Irlanda 4
JO - Giordania 4
KZ - Kazakistan 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
EG - Egitto 3
GT - Guatemala 3
LB - Libano 3
SA - Arabia Saudita 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
GE - Georgia 2
JM - Giamaica 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
TT - Trinidad e Tobago 1
UG - Uganda 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.352
Città #
Singapore 694
Ashburn 541
Fairfield 473
Woodbridge 437
Santa Clara 314
Jacksonville 303
Beijing 280
Houston 279
Hong Kong 275
Chandler 267
San Jose 199
Ann Arbor 189
Wilmington 176
Cambridge 172
Seattle 157
Los Angeles 145
Izmir 129
Nanjing 99
Princeton 92
Munich 83
New York 79
Ho Chi Minh City 74
Helsinki 65
Dallas 62
Buffalo 53
Jakarta 50
Shanghai 48
Mexico City 46
São Paulo 46
Milan 44
Warsaw 42
Council Bluffs 39
San Diego 38
Boardman 36
Addison 35
Hanoi 35
Tianjin 35
Hefei 34
Hebei 31
Nanchang 30
Turku 27
Shenyang 25
Changsha 24
Jiaxing 24
London 22
Bremen 21
Vienna 21
Denver 20
Dong Ket 20
Rio de Janeiro 20
Chicago 18
San Mateo 18
Chennai 17
Moscow 17
Brooklyn 16
Montreal 16
Norwalk 16
Nuremberg 16
Orem 16
Johannesburg 15
Tokyo 15
Atlanta 14
Boston 14
Lauterbourg 14
Curitiba 13
Falkenstein 13
Phoenix 13
Toronto 13
Washington 13
Brasília 12
Dearborn 12
Poplar 12
Guangzhou 11
Redwood City 11
San Francisco 11
Belo Horizonte 10
Brno 10
Ferrara 10
Frankfurt am Main 10
Ningbo 10
Ankara 9
Campinas 9
Haiphong 9
Jinan 9
Mountain View 9
Philadelphia 9
Taizhou 9
Falls Church 8
Hangzhou 8
Nairobi 8
Porto Alegre 8
Rome 8
Zhengzhou 8
Baghdad 7
Brussels 7
Charlotte 7
Da Nang 7
Genoa 7
Krasnodar 7
Manchester 7
Totale 7.016
Nome #
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 219
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 211
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 209
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 202
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 187
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 177
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 176
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 172
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 171
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 171
Airway smooth muscle biochemistry and asthma 168
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 166
Enfisema polmonare: prospettive di terapia 165
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 163
Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement 162
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 161
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 160
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 157
Helicobacter pylori and chronic bronchitis 156
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 152
Asthma progression and mortality: The role of inhaled corticosteroids 152
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 150
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 147
Inhaled corticosteroids in COPD: Friend or foe? 143
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 142
Altri problemi di patologia respiratoria 141
Anti-inflammatory treatments for asthma: Past, present, future 140
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 138
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 138
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 138
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 137
Blood eosinophils for the management of COPD patients? 136
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 135
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 134
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 134
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 133
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 133
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 133
Inhaled corticosteroid containing combinations and mortality in COPD 126
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 124
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 122
What can we learn from late-onset and occupational asthma? 121
Prevention of Chronic Obstructive Pulmonary Disease 120
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 118
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 117
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 114
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 113
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 113
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 112
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 111
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 111
Severity of airflow limitation is associated with severity of airway inflammation in smokers 111
Neutrophils and asthma. 110
Mechanism of occupational asthma 108
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 107
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 107
Neutrophils and Asthma 105
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 104
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 103
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 103
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 103
Chronic cough in adults 103
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 102
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 100
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 97
Guidelines and recommendations for the clinical use of bronchoalveolar lavage in asthma 95
Management of chronic refractory cough in adults 95
Glucocorticoidi 94
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 94
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 91
HLA class II molecules and asthma induced by toleune diisocyanate 91
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 85
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 83
Evaluation by self-monitoring and noninvasive measures 81
Small airway dysfunction: not so silent after all? 81
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 71
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 70
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 68
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 58
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 56
Rate of Decline of FEV1 as Biomarker of Survival? 53
null 50
A person-centred clinical approach to the multimorbid patient with COPD 49
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 48
null 45
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 42
Detecting Small Airways Dysfunction in Asthma: Rationale, Findings, and Future of ATLANTIS 1
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort 1
Totale 10.496
Categoria #
all - tutte 54.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.613
Totale 56.199


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021545 0 0 0 0 0 0 30 106 27 109 148 125
2021/2022797 28 53 49 61 61 25 25 46 36 55 71 287
2022/2023646 78 16 40 79 115 86 36 59 74 3 41 19
2023/2024390 42 48 20 15 25 54 13 25 15 5 11 117
2024/20251.783 38 59 155 47 236 160 29 61 278 221 271 228
2025/20263.322 564 221 431 653 782 355 316 0 0 0 0 0
Totale 10.496